FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|2 Jul 2013||Submitted||Original manuscript|
|13 Jul 2013||Author responded||Author comments - Aziz ZAANAN|
|Resubmission - Version 2|
|13 Jul 2013||Submitted||Manuscript version 2|
|18 Dec 2013||Reviewed||Reviewer Report - Erkan Topkan|
|3 Apr 2014||Reviewed||Reviewer Report - Raphaël Maréchal|
|8 Apr 2014||Reviewed||Reviewer Report - Ali Shamseddine|
|14 May 2014||Author responded||Author comments - Aziz ZAANAN|
|Resubmission - Version 3|
|14 May 2014||Submitted||Manuscript version 3|
|2 Jun 2014||Reviewed||Reviewer Report - Erkan Topkan|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|9 Jun 2014||Editorially accepted|
|14 Jun 2014||Article published||10.1186/1471-2407-14-441|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.